{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:55:05Z","timestamp":1772556905798,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010133","name":"Aarne Koskelon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Cardiac Foundation"},{"name":"Finnish State funding for university-level health research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00392-021-01823-0","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T10:02:43Z","timestamp":1615111363000},"page":"604-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-2074","authenticated-orcid":false,"given":"Antoine","family":"Kimmoun","sequence":"first","affiliation":[]},{"given":"Kevin","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[]},{"given":"Tuukka","family":"Tarvasm\u00e4ki","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Levy","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[]},{"given":"Sebastien","family":"Gibot","sequence":"additional","affiliation":[]},{"name":"CardShock Investigators and the GREAT network","sequence":"additional","affiliation":[]},{"given":"Katerina","family":"Koniari","sequence":"additional","affiliation":[]},{"given":"Astrinos","family":"Voumvourakis","sequence":"additional","affiliation":[]},{"given":"Apostolos","family":"Karavidas","sequence":"additional","affiliation":[]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Sans-Rosello","sequence":"additional","affiliation":[]},{"given":"Montserrat","family":"Vila","sequence":"additional","affiliation":[]},{"given":"Albert","family":"Duran-Cambra","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Sionis","sequence":"additional","affiliation":[]},{"given":"Jiri","family":"Parenica","sequence":"additional","affiliation":[]},{"given":"Roman","family":"Stipal","sequence":"additional","affiliation":[]},{"given":"Ondrej","family":"Ludka","sequence":"additional","affiliation":[]},{"given":"Marie","family":"Palsuva","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Ganovska","sequence":"additional","affiliation":[]},{"given":"Petr","family":"Kubena","sequence":"additional","affiliation":[]},{"given":"Jindrich","family":"Spinar","sequence":"additional","affiliation":[]},{"given":"Matias G.","family":"Lindholm","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[]},{"given":"Tom","family":"B\u00e4cklund","sequence":"additional","affiliation":[]},{"given":"Johan","family":"Lassus","sequence":"additional","affiliation":[]},{"given":"Raija","family":"Jurkko","sequence":"additional","affiliation":[]},{"given":"Heli","family":"Tolppanen","sequence":"additional","affiliation":[]},{"given":"Markku S.","family":"Nieminen","sequence":"additional","affiliation":[]},{"given":"Kristiina","family":"J\u00e4rvinen","sequence":"additional","affiliation":[]},{"given":"Tuomo","family":"Nieminen","sequence":"additional","affiliation":[]},{"given":"Kari","family":"Pulkki","sequence":"additional","affiliation":[]},{"given":"Leena","family":"Soininen","sequence":"additional","affiliation":[]},{"given":"Reijo","family":"Sund","sequence":"additional","affiliation":[]},{"given":"Ilkka","family":"Tierala","sequence":"additional","affiliation":[]},{"given":"Jukka","family":"Tolonen","sequence":"additional","affiliation":[]},{"given":"Marjut","family":"Varpula","sequence":"additional","affiliation":[]},{"given":"Tuomas","family":"Korva","sequence":"additional","affiliation":[]},{"given":"Mervi","family":"Pietil\u00e4","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Pitk\u00e4l\u00e4","sequence":"additional","affiliation":[]},{"given":"Rossella","family":"Marino","sequence":"additional","affiliation":[]},{"given":"Salvatore","family":"Di\u00a0Somma","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[]},{"given":"Michela","family":"Bulgari","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Lazzarini","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Carubelli","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Jose","family":"Silva-Cardoso","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Paiva","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Rangel","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Maria J\u00falia","family":"Maciel","sequence":"additional","affiliation":[]},{"given":"Marek","family":"Banaszewski","sequence":"additional","affiliation":[]},{"given":"Janina","family":"Stepinska","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Skrobisz","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"G\u00f3ral","sequence":"additional","affiliation":[]},{"given":"Uwe","family":"Zeymer","sequence":"additional","affiliation":[]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1922","volume":"22","author":"O Chioncel","year":"2020","unstructured":"Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, Harjola VP, Antohi EL, Arrigo M, Gal TB, Celutkiene J, Collins SP, DeBacker D, Iliescu VA, Jankowska E, Jaarsma T, Keramida K, Lainscak M, Lund LH, Lyon AR, Masip J, Metra M, Miro O, Mortara A, Mueller C, Mullens W, Nikolaou M, Piepoli M, Price S, Rosano G, Vieillard-Baron A, Weinstein JM, Anker SD, Filippatos G, Ruschitzka F, Coats AJS, Seferovic P (2020) Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 22:1315\u20131341. https:\/\/doi.org\/10.1002\/ejhf.1922","journal-title":"Eur J Heart Fail"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG (2017) Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 136:e232\u2013e268. https:\/\/doi.org\/10.1161\/CIR.0000000000000525","journal-title":"Circulation"},{"key":"1823_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 37:2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J."},{"key":"1823_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","volume":"117","author":"HR Reynolds","year":"2008","unstructured":"Reynolds HR, Hochman JS (2008) Cardiogenic shock. Current concepts and improving outcomes. Circulation 117:686\u2013697. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.613596","journal-title":"Circulation"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00392-011-0403-3","volume":"101","author":"R Prondzinsky","year":"2012","unstructured":"Prondzinsky R, Unverzagt S, Lemm H, Wegener NA, Schlitt A, Heinroth KM, Dietz S, Buerke U, Kellner P, Loppnow H, Fiedler MG, Thiery J, Werdan K, Buerke M (2012) Interleukin-6,-7,-8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol 101:375\u2013384. https:\/\/doi.org\/10.1007\/s00392-011-0403-3","journal-title":"Clin Res Cardiol"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"e011991","DOI":"10.1161\/JAHA.119.011991","volume":"8","author":"C Vahdatpour","year":"2019","unstructured":"Vahdatpour C, Collins D, Goldberg S (2019) Cardiogenic shock. J Am Heart Assoc 8:e011991. https:\/\/doi.org\/10.1161\/JAHA.119.011991","journal-title":"J Am Heart Assoc"},{"key":"1823_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.phrs.2015.07.027","volume":"100","author":"J Lemarie","year":"2015","unstructured":"Lemarie J, Boufenzer A, Derive M, Gibot S (2015) The Triggering Receptor expressed on myeloid cells-1: a new player during myocardial infarction. Pharmacol Res 100:261\u2013265. https:\/\/doi.org\/10.1016\/j.phrs.2015.07.027","journal-title":"Pharmacol Res"},{"key":"1823_CR8","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.4049\/jimmunol.170.7.3812","volume":"170","author":"JR Bleharski","year":"2003","unstructured":"Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL (2003) A role for triggering receptor expressed on myeloid cells-1 in host defense during the early induced and adaptive phases of the immune response. J Immunol 170:3812. https:\/\/doi.org\/10.4049\/jimmunol.170.7.3812","journal-title":"J Immunol"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/cvr\/cvy018","volume":"114","author":"L Jolly","year":"2018","unstructured":"Jolly L, Carrasco K, Derive M, Lemari\u00e9 J, Boufenzer A, Gibot S (2018) Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. Cardiovasc Res 114:907\u2013918. https:\/\/doi.org\/10.1093\/cvr\/cvy018","journal-title":"Cardiovasc Res"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/ALN.0000000000000078","volume":"120","author":"M Derive","year":"2014","unstructured":"Derive M, Boufenzer A, Gibot S (2014) Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate. Anesthesiology 120:935\u2013942. https:\/\/doi.org\/10.1097\/ALN.0000000000000078","journal-title":"Anesthesiology"},{"key":"1823_CR11","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/CIRCRESAHA.116.305628","volume":"116","author":"A Boufenzer","year":"2015","unstructured":"Boufenzer A, Lemari\u00e9 J, Simon T, Derive M, Bouazza Y, Tran N, Maskali F, Groubatch F, Bonnin P, Bastien C, Bruneval P, Marie PY, Cohen R, Danchin N, Silvestre JS, Ait-Oufella H, Gibot S (2015) TREM-1 mediates inflammatory injury and cardiac remodeling following myocardial infarction. Circ Res 116:1772\u20131782. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305628","journal-title":"Circ Res"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ehf2.12029","volume":"2","author":"J Lemari\u00e9","year":"2015","unstructured":"Lemari\u00e9 J, Boufenzer A, Popovic B, Tran N, Groubatch F, Derive M, Labroca P, Barraud D, Gibot S (2015) Pharmacological inhibition of the triggering receptor expressed on myeloid cells-1 limits reperfusion injury in a porcine model of myocardial infarction. ESC Heart Fail 2:90\u201399. https:\/\/doi.org\/10.1002\/ehf2.12029","journal-title":"ESC Heart Fail"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccc.2019.08.004","volume":"36","author":"J Lemarie","year":"2020","unstructured":"Lemarie J, Gibot S (2020) Soluble triggering receptor expressed on myeloid cells-1: diagnosis or prognosis? Crit Care Clin 36:41\u201354. https:\/\/doi.org\/10.1016\/j.ccc.2019.08.004","journal-title":"Crit Care Clin"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"VP Harjola","year":"2015","unstructured":"Harjola VP, Lassus J, Sionis A, K\u00f8ber L, Tarvasm\u00e4ki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Di Somma S, Tolppanen H, Zeymer U, Thiele H, Nieminen MS, Mebazaa A, CardShock Study Investigators; GREAT network (2015) Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail 17:501\u2013509. https:\/\/doi.org\/10.1002\/ejhf.260","journal-title":"Eur J Heart Fail"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12879-016-1893-4","volume":"16","author":"PE Charles","year":"2016","unstructured":"Charles PE, Noel R, Massin F, Guy J, Bollaert PE, Quenot JP, Gibot S (2016) Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infect Dis 16:559. https:\/\/doi.org\/10.1186\/s12879-016-1893-4","journal-title":"BMC Infect Dis"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","volume":"21","author":"JW Ford","year":"2009","unstructured":"Ford JW, McVicar DW (2009) TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 21:38\u201346. https:\/\/doi.org\/10.1016\/j.coi.2009.01.009","journal-title":"Curr Opin Immunol"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.imlet.2007.11.021","volume":"116","author":"AS Tessarz","year":"2008","unstructured":"Tessarz AS, Cerwenka A (2008) The TREM-1\/DAP12 pathway. Immunol Lett 116:111\u2013116. https:\/\/doi.org\/10.1016\/j.imlet.2007.11.021","journal-title":"Immunol Lett"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/35074114","volume":"410","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103\u20131107. https:\/\/doi.org\/10.1038\/35074114","journal-title":"Nature"},{"key":"1823_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ecco-jcc\/jjx129","volume":"12","author":"T K\u00f6kten","year":"2018","unstructured":"K\u00f6kten T, Gibot S, Lepage P, D\u2019Alessio S, Hablot J, Ndiaye NC, Busby-Venner H, Monot C, Garnier B, Moulin D, Jouzeau JY, Hansmannel F, Danese S, Gu\u00e9ant JL, Muller S, Peyrin-Biroulet L (2018) TREM-1 inhibition restores impaired autophagy activity and reduces colitis in mice. J Crohns Colitis 12:230\u2013244. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx129","journal-title":"J Crohns Colitis"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.jacc.2016.10.015","volume":"68","author":"J Joffre","year":"2016","unstructured":"Joffre J, Potteaux S, Zeboudj L, Loyer X, Boufenzer A, Laurans L, Esposito B, Vandestienne M, de Jager SC, H\u00e9nique C, Zlatanova I, Taleb S, Bruneval P, Tedgui A, Mallat Z, Gibot S, Ait-Oufella H (2016) Genetic and pharmacological inhibition of TREM-1 limits the development of experimental atherosclerosis. J Am Coll Cardiol 68:2776\u20132793. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.015","journal-title":"J Am Coll Cardiol"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00134-009-1463-y","volume":"35","author":"GJ Oudhuis","year":"2009","unstructured":"Oudhuis GJ, Beuving J, Bergmans D, Stobberingh EE, ten Velde G, Linssen CF, Verbon A (2009) Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 35:1265\u20131270. https:\/\/doi.org\/10.1007\/s00134-009-1463-y","journal-title":"Intensive Care Med"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1164\/rccm.201201-0037OC","volume":"186","author":"S Gibot","year":"2012","unstructured":"Gibot S, B\u00e9n\u00e9 MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho BM, Quenot JP, Bollaert PE, Faure G, Charles PE (2012) Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 186:65\u201371. https:\/\/doi.org\/10.1164\/rccm.201201-0037OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1823_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00134-020-06109-z","volume":"46","author":"B Fran\u00e7ois","year":"2020","unstructured":"Fran\u00e7ois B, Wittebole X, Ferrer R, Mira JP, Dugernier T, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Pickkers P, Vandenhende F, Garaud JJ, S\u00e1nchez M, Salcedo-Magguilli M, Laterre PF (2020) Nangibotide in patients with septic shock: a phase 2a randomized controlled clinical trial. Intensive Care Med 46:1425\u20131437. https:\/\/doi.org\/10.1007\/s00134-020-06109-z","journal-title":"Intensive Care Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01823-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T15:03:59Z","timestamp":1653923039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01823-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01823-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Antoine Kimmoun. A K received speaker\u2019s honoraria for lectures from Baxter, Aguettant and Aspen. Alexandre Mebazaa. AM reports personal fees from Orion, grants and personal fees from Roche, personal fees from Servier, personal fees from Otsuka, personal fees from Philips, grants and personal fees from Adrenomed, personal fees from NeuroTronik, grants and personal fees from 4TEEN4, personal fees from Sanofi. S\u00e9bastien Gibot. S G is a cofounder of INOTREM, a company developing an inhibitor of TREM-1. The remaining author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}